Additionally, the elevated levels of Δ133p53β isoform promote an immunosuppressive environment in prostate cancer by regulating the expression of CD274, which encodes PD-L1 [84] and boosts a chemoresistant environment in glioblastoma [85], leading to aggressive cancer. This evidence concerns the gene CD274 and prostate carcinoma.